{"input_url":"https://www.hotsr.com/news/2026/jul/24/fda-panel-narrowly-backs-unapproved-peptide-drug/","gnews_decode":"https://www.hotsr.com/news/2026/jul/24/fda-panel-narrowly-backs-unapproved-peptide-drug/","http_status":200,"final_url":"https://www.hotsr.com/news/2026/jul/24/fda-panel-narrowly-backs-unapproved-peptide-drug/","html_length":147475,"trafilatura_result":"ok","text_length":5315,"text_preview":"WASHINGTON — Health advisers met Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective.\nIn the first of several votes, the panel of Food and Drug Administration experts narrowly voted 8-6 i","verdict":"OK"}